中华传染病杂志
中華傳染病雜誌
중화전염병잡지
CHINESE JOURNAL OF INFECTIOUS DISEASES
1999年
3期
159-161
,共3页
赵西平%沈汉馨%杨东亮%郑昕%王宝菊%汪由坤%郝连杰
趙西平%瀋漢馨%楊東亮%鄭昕%王寶菊%汪由坤%郝連傑
조서평%침한형%양동량%정흔%왕보국%왕유곤%학련걸
肝炎,丙型%丙型肝炎病毒Ns5抗原%Fas抗原%干扰素治疗
肝炎,丙型%丙型肝炎病毒Ns5抗原%Fas抗原%榦擾素治療
간염,병형%병형간염병독Ns5항원%Fas항원%간우소치료
Hepatitis C HCV NS5 protein Fas antigen Interferon therapy
目的 探讨丙型肝炎患者肝组织中HCV Ns5和Fas抗原表达及其与肝组织损伤和干扰素治疗反应的关系.方法 应用a干扰素对一组慢性丙型肝炎患者进行24周治疗,停药后随访6个月,以血清丙氨酸转氨酶(ALT)恢复正常及血清HCV RNA持续阴转为完全应答标准,采用免疫组化方法检测组织中病毒和Fas抗原表达状况.结果 29例慢性丙型肝炎患者肝组织中,HCV NS5和Fas抗原呈阳性者均为19例(65.5%),两者在肝组织中的表达显著相关;单因素相关分析时,两者均与组织病变程度有关,但多因素分析表明只有HCV NS5抗原表达水平与组织炎症活动度呈正相关.治疗和随访结束时分别有17例(58.6%)和15例(51.7%)患者表现为近期和远期完全应答.治疗前Fas表达水平与干扰素应答有关,但未见HCV NS5水平与干扰素应答有明显关系;5例随访结束时重复肝穿,3例完全应答者病毒表达显著受抑,但Fas抗原无明显改变,2例无应答者病毒表达无明显改变甚或增强,而Fas表达均增强.结论 慢性丙型肝炎肝组织中HCV Ns5表达在慢性丙型肝炎发病过程中有重要意义;Fas抗原表达水平与组织中病毒表达相关;治疗前肝组织Fas表达状况与干扰素治疗反应有一定联系.
目的 探討丙型肝炎患者肝組織中HCV Ns5和Fas抗原錶達及其與肝組織損傷和榦擾素治療反應的關繫.方法 應用a榦擾素對一組慢性丙型肝炎患者進行24週治療,停藥後隨訪6箇月,以血清丙氨痠轉氨酶(ALT)恢複正常及血清HCV RNA持續陰轉為完全應答標準,採用免疫組化方法檢測組織中病毒和Fas抗原錶達狀況.結果 29例慢性丙型肝炎患者肝組織中,HCV NS5和Fas抗原呈暘性者均為19例(65.5%),兩者在肝組織中的錶達顯著相關;單因素相關分析時,兩者均與組織病變程度有關,但多因素分析錶明隻有HCV NS5抗原錶達水平與組織炎癥活動度呈正相關.治療和隨訪結束時分彆有17例(58.6%)和15例(51.7%)患者錶現為近期和遠期完全應答.治療前Fas錶達水平與榦擾素應答有關,但未見HCV NS5水平與榦擾素應答有明顯關繫;5例隨訪結束時重複肝穿,3例完全應答者病毒錶達顯著受抑,但Fas抗原無明顯改變,2例無應答者病毒錶達無明顯改變甚或增彊,而Fas錶達均增彊.結論 慢性丙型肝炎肝組織中HCV Ns5錶達在慢性丙型肝炎髮病過程中有重要意義;Fas抗原錶達水平與組織中病毒錶達相關;治療前肝組織Fas錶達狀況與榦擾素治療反應有一定聯繫.
목적 탐토병형간염환자간조직중HCV Ns5화Fas항원표체급기여간조직손상화간우소치료반응적관계.방법 응용a간우소대일조만성병형간염환자진행24주치료,정약후수방6개월,이혈청병안산전안매(ALT)회복정상급혈청HCV RNA지속음전위완전응답표준,채용면역조화방법검측조직중병독화Fas항원표체상황.결과 29례만성병형간염환자간조직중,HCV NS5화Fas항원정양성자균위19례(65.5%),량자재간조직중적표체현저상관;단인소상관분석시,량자균여조직병변정도유관,단다인소분석표명지유HCV NS5항원표체수평여조직염증활동도정정상관.치료화수방결속시분별유17례(58.6%)화15례(51.7%)환자표현위근기화원기완전응답.치료전Fas표체수평여간우소응답유관,단미견HCV NS5수평여간우소응답유명현관계;5례수방결속시중복간천,3례완전응답자병독표체현저수억,단Fas항원무명현개변,2례무응답자병독표체무명현개변심혹증강,이Fas표체균증강.결론 만성병형간염간조직중HCV Ns5표체재만성병형간염발병과정중유중요의의;Fas항원표체수평여조직중병독표체상관;치료전간조직Fas표체상황여간우소치료반응유일정련계.
Objective To study the expression of viral and Fas antigens in the livers of patients with chronic hepatitis C(CHC)and their relationship tO liver damage and response tO interferon(IFN)therapy.Methods HCV NS5 protein and Fas antigen in the liver of patients with CHC were detected immunohistochemically before and after 24-week treatment of interferon.The complete response(CR)was defined as continu OUS HCV RNA seroconversion and sustained ALT level normalization.Results Among the 29 subjects with CHC,HCV NS5 protien and Fas antigen were both detected tO be positive in 19(65.5%)cases.There was a positive correlation between the expression of HCV NS5 and Fas antigen in liver.Both the expression of Fas antigen and the expression of HCV NS5 protein were correlated to liver inflammatory activity in the patients with CHC by univariate analysis,while only HCV NS5 protein had a correlation with liver inflammatory activity by multivariate analysis.There were 17(58.6%)and 15(51.7%)cases with short and long-term CR to IFN therapy in total Fas antigen expression level in liver was correlated tO the response of INF treatment,but no correlation was found between the expression of viral antigen and IFN treatment response.Conclusions There results showed that the expression of HCV NS5 protein in the liver of patients with CHC maybe take an important role in the pathogenesis of CHC.The expression of Fas antigen is correlated to HCV antigen expression and maybe an influential factor on the result of IFN therapy.